MedLife announces 50 million Euro credit limit increase

MedLife announces the authorization of the Board of Directors to increase the syndicated loan by up to 50 million Euro, thus reaching a total of 330 million Euro.

The syndicate of banks that signed the credit limit increase is formed by Banca Comercială Română (BCR) – as coordinator, lead arranger, documentation agent, facility and guarantee agent, also acting as lender -, as well as other credit institutions: Raiffeisen Bank, BRD Groupe Société Générale and Banca Transilvania, as lead arrangers and lenders, and ING Bank N.V. Amsterdam Bucharest Branch, as lender.

„Since the listing until now, MedLife has been an acquisitive company, with excellent results both in terms of acquiring new companies and in terms of their integration processes. As a result, the Group has recorded turnover increases of over 20% on average in the past 5 years, driven by both organic developments and acquisitions. 2024 was a year dedicated to consolidation and, despite a much slower economic growth at national level, we managed to improve the Group’s financial and operational performance, as well as reduce the level of indebtedness”, said Mihai Marcu, Chairman and CEO of MedLife Group.

„This new syndicated transaction reaffirms our commitment to supporting local champions who invest in sustainable development and international expansion. As lead arranger, BCR coordinated the structuring of a flexible financing package tailored to the needs of a group undergoing an accelerated growth phase. We believe in MedLife’s strategy and are proud to contribute to a project that is shaping the future of the healthcare ecosystem in the region, making a meaningful difference both in Romania and beyond”, said Raluca Orha, Head of Loan Syndication BCR.

In 2024 MedLife focused on investments in new robots, product diversification and consolidation through new organic projects and acquisitions at national level. The pro-forma consolidated turnover reached over RON 2.7 billion (EUR 555 million), up 25% compared to 2023. Thus, the Group became the first Romanian private healthcare company to exceed half a billion euros in turnover in 2024. Also, the pro-forma EBITDA reached RON 412 million in 2024 compared to RON 317 million in the previous year.

„Maintaining a prudent approach, the additional funds will be used primarily to complete the ongoing projects, but also for potential acquisitions of companies, which would allow the Group to maintain the current trend of expansion and consolidation of the medical services market, while capturing additional profitability. Looking ahead, there will be a period in which we will put more emphasis on genetics, nutrition, sports and prevention in general. We firmly believe that these areas are part of the medicine of the future and we will make significant investments in this direction”, said Mihai Marcu, Chairman and CEO of MedLife Group.

Currently, MedLife Group is one of the largest operators at regional level, already having an active presence in three countries: Romania, Hungary and recently, the Republic of Moldova. In the medium and long term, the company aims to test other markets in the region, the new funds accessed being a reserve in this regard.